Bank of New York Mellon Corp grew its stake in shares of iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report) by 19.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,017 shares of the company’s stock after acquiring an additional 4,979 shares during the period. Bank of New York Mellon Corp’s holdings in iShares iBonds Dec 2027 Term Corporate ETF were worth $743,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Captrust Financial Advisors lifted its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 36.4% during the third quarter. Captrust Financial Advisors now owns 414,425 shares of the company’s stock worth $10,100,000 after purchasing an additional 110,597 shares during the last quarter. Flow Traders U.S. LLC bought a new position in iShares iBonds Dec 2027 Term Corporate ETF during the 3rd quarter worth approximately $543,000. Integrated Wealth Concepts LLC grew its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 13.1% in the 3rd quarter. Integrated Wealth Concepts LLC now owns 126,359 shares of the company’s stock worth $3,079,000 after acquiring an additional 14,656 shares in the last quarter. Confluence Investment Management LLC increased its holdings in shares of iShares iBonds Dec 2027 Term Corporate ETF by 0.8% in the 4th quarter. Confluence Investment Management LLC now owns 165,459 shares of the company’s stock valued at $3,964,000 after acquiring an additional 1,370 shares during the last quarter. Finally, GAMMA Investing LLC raised its position in shares of iShares iBonds Dec 2027 Term Corporate ETF by 33.0% during the 4th quarter. GAMMA Investing LLC now owns 150,847 shares of the company’s stock valued at $3,614,000 after acquiring an additional 37,470 shares in the last quarter.
iShares iBonds Dec 2027 Term Corporate ETF Price Performance
iShares iBonds Dec 2027 Term Corporate ETF stock opened at $24.13 on Thursday. iShares iBonds Dec 2027 Term Corporate ETF has a 12 month low of $23.44 and a 12 month high of $24.68. The company has a fifty day moving average price of $24.06 and a two-hundred day moving average price of $24.09.
About iShares iBonds Dec 2027 Term Corporate ETF
The iShares iBonds Dec 2027 Term Corporate ETF (IBDS) is an exchange-traded fund that mostly invests in investment grade fixed income. The fund tracks a Bloomberg global index of USD-denominated, investment-grade corporate bonds maturing between December 31, 2026 and December 16, 2027. IBDS was launched on Sep 12, 2017 and is managed by BlackRock.
Further Reading
- Five stocks we like better than iShares iBonds Dec 2027 Term Corporate ETF
- When to Sell a Stock for Profit or Loss
- Energy Transfer: Powering Data With Dividends and Diversification
- What Are Dividend Achievers? An Introduction
- Qualcomm Stock Is Coiling for a Breakout
- Short Selling – The Pros and Cons
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding IBDS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares iBonds Dec 2027 Term Corporate ETF (NYSEARCA:IBDS – Free Report).
Receive News & Ratings for iShares iBonds Dec 2027 Term Corporate ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares iBonds Dec 2027 Term Corporate ETF and related companies with MarketBeat.com's FREE daily email newsletter.
